New UCLA-led research finds that infants born full term to mothers who were infected with COVID-19 during pregnancy had three times the risk of having respiratory distress compared with unexposed ...

HealthDay News — The FDA has approved Surfaxin (lucinactant) to prevent respiratory distress syndrome (RDS) in premature infants. Premature infants born before 37 weeks’ gestation often cannot produce ...

As several European countries are currently detecting respiratory syncytial virus (RSV) infections, ECDC issues rapid ...

Please provide your email address to receive an email when new articles are posted on . Minimally invasive surfactant therapy did not lower mortality among preterm infants with respiratory distress ...

ByHeart voluntarily recalls two batches of Whole Nutrition Infant Formula amid an FDA investigation into a nationwide ...

The most likely diagnosis for this infant is bronchiolitis. This illness is the most common reason for hospitalization of an infant or preschool-age child in the United States. [1] Bronchiolitis is ...

The California Department of Public Health (CDPH) has announced a multistate outbreak of infant botulism connected to ByHeart ...

Objective: The aim of the study was to measure pulmonary mechanics in infants with respiratory distress syndrome before extubation and to correlate pulmonary function values with successful extubation ...

The Food and Drug Administration is investigating 13 cases of infant botulism linked to baby formula that has since been ...

Contaminated batches of infant formula recalled nationwide for potential botulism contamination were sold in the Augusta area ...